drugset / Trial / NCT04737876
A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults
RandomizedParallel-groupSingle-blindOther
Summary
The purpose of study BMX-02-001 is to evaluate the safety, tolerability and feasibility of orally administered BX002-A to deliver viable bacteriophages to the gut.
Timeline
- Start
- 2020-10-28
- Primary completion
- 2020-12-21
- Completion
- 2020-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BX002-A | Unknown | 1 ml | Oral |
Indications
No indication recorded.